Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Circulation|September 20, 2017
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart AssociationSean van Diepen, Jason N Katz, Nancy M Albert, et al.
Journal of the American College of Cardiology|October 8, 2021
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.
Journal of Thrombosis and Thrombolysis|February 22, 2019
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE TrialJeffrey B Washam, Stefan H Hohnloser, Renato D Lopes, et al.
Journal of the American Heart Association|May 27, 2022
Cangrelor Use Patterns and Transition to Oral P2Y<sub>12</sub> Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO RegistryJennifer A Rymer, Deepak L Bhatt, Dominick J Angiolillo, et al.
Circulation|November 22, 2019
Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE TrialFrederik Dalgaard, Hillary Mulder, Daniel M Wojdyla, et al.
Lancet (London, England)|March 10, 2015
Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)Jeffrey B Washam, Susanna R Stevens, Yuliya Lokhnygina, et al.
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation|December 18, 2015
Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationJonathan P Piccini, Anne S Hellkamp, Jeffrey B Washam, et al.
American Heart Journal|December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillationSean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
JACC. Cardiovascular Interventions|August 20, 2016
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF TrialMatthew W Sherwood, Derek D Cyr, W Schuyler Jones, et al.
Pageof 5